Sow Hang Teo - 13 Feb 2025 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Signature
/s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol
CLB
Transactions as of
13 Feb 2025
Net transactions value
$0
Form type
4
Filing time
13 Feb 2025, 16:45:20 UTC
Previous filing
02 Dec 2024
Next filing
05 May 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Performance Shares Award $0 +7,692 $0.000000 7,692 13 Feb 2025 Common Stock 7,692 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Assuming the recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest on January 1, 2028, following the conclusion of a three-year performance period that began on January 1, 2025 and ends on December 31, 2027 (the "Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return on Invested Capital ("ROIC") among the Bloomberg Peer Group ("BPG"), and 200% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile of ROIC (equivalent to 100% up to 200% of the award).